Qiang Liu

Founder at Tangent Capital, Inc.

58 year

Consumer Services

Health Technology

Profile

Qiang Liu is the founder of Tangent Capital, Inc. (founded in 2006) and holds the title of Managing Director.
He is currently a Director at China Nuokang Bio-Pharmaceutical, Inc. (since 2006).
Mr. Liu was previously the President of BCTech Investments, Inc. (2007-2008).
He holds an MBA from York University (2000), a graduate degree from The University of New South Wales (1996), and an undergraduate degree from Jilin University (1989).

Qiang Liu active positions

Companies	Position	Start
China Nuokang Bio-Pharmaceutical, Inc. China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China.	Director/Board Member	2009-11-22
Tangent Capital, Inc.	Founder	2010-12-12

All active positions of Qiang Liu

Former positions of Qiang Liu

Companies	Position	End
BCTech Investments, Inc.	President	2008-11-30

See the detail of Qiang Liu's experience

Training of Qiang Liu

Jilin University	Undergraduate Degree
The University of New South Wales	Graduate Degree
York University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Qiang Liu's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
China Nuokang Bio-Pharmaceutical, Inc. China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China.	Health Technology
Tangent Capital, Inc.
BCTech Investments, Inc.

See company connections